Health, Fitness & Food

The Food and Drug Administration’s independent panel of advisors on Wednesday recommended GlaxoSmithKline’s RSV vaccine for adults ages 60 and older, though they flagged potential safety issues over nervous system disorders that may be tied to the shot. Ten of the FDA advisors said the safety data on GSK’s vaccine was adequate, while two said
0 Comments
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images The Food and Drug Administration’s independent advisors on Tuesday recommended what would be the world’s first RSV vaccine, a shot from Pfizer for adults ages 60 and older, despite safety concerns after two trial participants developed a rare neurological disorder.  A
0 Comments
Club holdings Amazon (AMZN), Wells Fargo (WFC) as well as Nvidia (NVDA) and Microsoft (MSFT) are in the news Wednesday. Here are the headlines and the implications for the Club’s investment thesis. Amazon completes health deal AMZN YTD mountain Amazon’s year-to-date stock performance. The news: Amazon completed its acquisition of primary-care provider One Medical, the
0 Comments
Paquita Bonillo, 84 years old, receives the fourth dose of Covid-19 and flu vaccine in the garden of the Feixa Llarga nursing home on September 26, 2022 in Barcelona, Spain. Zowy Voeten | Getty Images The flu vaccine has been 68% effective at preventing hospitalizations in children but has been less protective for seniors this
0 Comments
In this article PFE GSK-GB GSK Follow your favorite stocksCREATE FREE ACCOUNT This 1981 photo provided by the Centers for Disease Control and Prevention (CDC) shows an electron micrograph of Respiratory Syncytial Virus, also known as RSV. CDC via AP The Food and Drug Administration sees a possible risk of Guillain-Barre syndrome with Pfizer‘s RSV
0 Comments
Boxes of mifepristone, the first pill given in a medical abortion, are prepared for patients at Women’s Reproductive Clinic of New Mexico in Santa Teresa, U.S., January 13, 2023.  Evelyn Hockstein | Reuters A coalition of a dozen Democratic attorneys general sued the Food and Drug Administration on Friday to force the agency to drop
0 Comments
In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT A vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, September 8, 2022. Hannah Beier | Reuters Moderna on Thursday missed earnings expectations for the fourth quarter, as costs rose
0 Comments
The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare will not provide broader coverage of the Alzheimer’s drug Leqembi until it receives more evidence that the treatment is reasonable and necessary, according to the federal agency that runs the program for
0 Comments
Vials of the JYNNEOS Monkeypox vaccine are prepared at a pop-up vaccination clinic in Los Angeles, California, on August 9, 2022. Patrick T. Fallon | AFP | Getty Images The Centers for Disease Control and Prevention’s independent advisors on Wednesday unanimously recommended administering the two-dose Jynneos vaccine to adults at risk of mpox in the
0 Comments
Patrick Morrisey, attorney general of West Virginia, arrives before an event with U.S. President Donald Trump, not pictured, at the White House in Washington, D.C., on Thursday, Feb. 6, 2020. Al Drago | Bloomberg | Getty Images West Virginia’s attorney general is urging a judge to dismiss a lawsuit seeking to overturn the state’s restrictions
0 Comments
We’re buying 45 shares of Johnson & Johnson (JNJ) at roughly $158 each. Following Tuesday’s trade, Jim Cramer’s Charitable Trust will own 600 shares of J & J, increasing its weighting in the portfolio to about 3.27% from 3.03%. Wall Street’s selloff picked up steam Tuesday as last week’s hotter-than-expected inflation data has pushed bond
0 Comments
In this article BIIB ESALY 4523.T-JP Follow your favorite stocksCREATE FREE ACCOUNT Tek Image/science Photo Library | Science Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this summer, which would expand access to the pricey new antibody under Medicare. U.S. CEO Ivan
0 Comments
Philip O’Keefe, one of Synchron’s patients in the SWITCH clinical trial, using his BCI. Source: Synchron In a Brooklyn lab stuffed with 3D printers and a makeshift pickleball court, employees at a brain interface startup called Synchron are working on technology designed to transform daily life for people with paralysis. The Synchron Switch is implanted
0 Comments
Sen. Susan Collins (R-ME) speaks to reporters in the Senate Subway during a vote in the U.S. Capitol on September 08, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. senators on Friday called for Medicare to offer broad coverage of Alzheimer’s treatments approved by the Food and Drug Administration, warning that current restrictions
0 Comments
U.S. Senator John Fetterman (D-PA), leaves a classified briefing for U.S. Senators about the latest unknown objects shot down by the U.S. military, on Capitol Hill in Washington, U.S., February 14, 2023.  Evelyn Hockstein | Reuters Sen. John Fetterman, D-Pa., will receive inpatient hospital care for a few weeks as he seeks treatment for clinical
0 Comments
In this article LLY PFE Follow your favorite stocksCREATE FREE ACCOUNT Sharon Kimbrough went to the Black Women’s Expo in Atlanta to sell her memoir. Getting tested for Alzheimer’s was the furthest thing from her mind, but when nurses from Eli Lilly approached her about the company’s new trial, she decided to let them draw
0 Comments